Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (Q1)Dec 31, 2025 | (FY)Sep 30, 2025 | (Q4)Sep 30, 2025 | (Q3)Jun 30, 2025 | (Q2)Mar 31, 2025 | (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -1,674.07%-425K | -121.99%-424K | -3,217.65%-564K | -114.35%-493K | 209.18%606K | 119.29%27K | -105.67%-191K | -100.64%-17K | -132.90%-230K | -87.87%196K |
| Net income from continuing operations | 76.49%-2.52M | -512.23%-6M | -64.34%3.74M | 197.56%3.01M | -4.43%-2.03M | -167.29%-10.72M | -57.25%1.46M | 167.56%10.49M | -147.78%-3.08M | -117.30%-1.94M |
| Operating gains losses | -144.52%-65K | 41.75%1.23M | 190.83%99K | 290.31%373K | 255.23%611K | -85.40%146K | 113.32%867K | 96.72%-109K | 44.00%-196K | 105.76%172K |
| Depreciation and amortization | ---- | --0 | ---- | ---- | ---- | ---- | 133.33%21K | 950.00%21K | --0 | ---- |
| Asset impairment expenditure | ---- | --0 | --0 | ---- | ---- | ---- | 7,364.71%1.27M | --0 | 6,445.00%1.27M | ---- |
| Remuneration paid in stock | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- |
| Unrealized gains and losses of investment securities | -76.82%2.35M | 235.03%4.01M | 61.94%-3.86M | -189.23%-3.6M | 88.29%1.32M | 317.79%10.15M | -70.71%-2.97M | -155.78%-10.13M | 156.89%4.03M | 106.36%700K |
| Remuneration paid in stock | ---- | --0 | --0 | --0 | --0 | --0 | -48.92%450K | -161.06%-185K | -16.26%170K | -11.15%231K |
| Other non cashItems | -269.23%-1.12M | -10.62%1.15M | -94.99%52K | 40.71%-201K | 15,875.00%631K | 13.14%663K | -53.44%1.28M | -80.83%1.04M | 69.49%-339K | 99.04%-4K |
| Change In working capital | 545.45%931K | 68.44%-809K | 47.32%-599K | 96.50%-73K | -93.06%72K | 44.71%-209K | -178.31%-2.56M | 32.28%-1.14M | -180.19%-2.09M | -59.22%1.04M |
| -Change in receivables | ---- | 98.80%-12K | -144.83%-26K | 100.07%1K | 550.00%13K | --0 | -1,234.67%-1M | 256.76%58K | -193.07%-1.36M | 100.16%2K |
| -Change in prepaid assets | 0.00%3K | 171.43%10K | -110.00%-2K | -99.58%1K | 103.60%8K | 105.88%3K | -160.87%-14K | -52.38%20K | 4,680.00%239K | -3,271.43%-222K |
| -Change in payables and accrued expense | 280.33%928K | -137.06%-351K | -93.56%-571K | 105.59%8K | -102.20%-32K | 443.66%244K | 153.21%947K | -166.14%-295K | -941.18%-143K | 927.27%1.46M |
| -Change in other current liabilities | ---- | 81.72%-456K | ---- | ---- | ---- | 17.39%-456K | -184.55%-2.5M | 56.81%-920K | -173.57%-824K | -105.02%-199K |
| -Change in other working capital | ---- | ---- | ---- | 89.93%-83K | --83K | ---456K | ---- | ---- | ---824K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -1,674.07%-425K | -121.99%-424K | -3,217.65%-564K | -114.35%-493K | 209.18%606K | 119.29%27K | -105.67%-191K | -100.64%-17K | -132.90%-230K | -87.87%196K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 0 | 0 | 113.77%200K | 0 | 0 | 0 | |
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | 113.77%200K | --0 | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | --0 | --0 | --0 | --0 | --0 | 113.77%200K | --0 | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 3,125.81%1M | 250K | 750K | 0 | 0 | 100.51%31K | 0 | 0 | 0 | |
| Net common stock issuance | ---- | --1M | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- |
| Proceeds from stock option exercised by employees | ---- | --0 | --0 | --0 | --0 | --0 | -87.40%31K | --0 | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | 3,125.81%1M | --250K | --750K | --0 | --0 | 100.51%31K | --0 | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 702.44%658K | 105.00%82K | 881.82%972K | 121.36%715K | -16.67%110K | 105.00%82K | -99.06%40K | -65.51%99K | -73.68%323K | -95.33%132K |
| Current changes in cash | -1,674.07%-425K | 1,271.43%576K | -1,993.33%-314K | 211.74%257K | 209.18%606K | -70.33%27K | 101.00%42K | 93.88%-15K | 77.21%-230K | 112.56%196K |
| Effect of exchange rate changes | --0 | --0 | --0 | --0 | 80.00%-1K | 0.00%1K | --0 | 0.00%-2K | -91.30%6K | 86.11%-5K |
| End cash Position | 111.82%233K | 702.44%658K | 702.44%658K | 881.82%972K | 121.36%715K | -16.67%110K | 105.00%82K | 105.00%82K | -65.51%99K | -73.68%323K |
| Free cash from | -1,674.07%-425K | -121.99%-424K | -3,217.65%-564K | -114.35%-493K | 209.18%606K | 119.29%27K | -105.67%-191K | -100.63%-17K | -132.90%-230K | -87.87%196K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.